ATE526585T1 - Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon - Google Patents

Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon

Info

Publication number
ATE526585T1
ATE526585T1 AT06707378T AT06707378T ATE526585T1 AT E526585 T1 ATE526585 T1 AT E526585T1 AT 06707378 T AT06707378 T AT 06707378T AT 06707378 T AT06707378 T AT 06707378T AT E526585 T1 ATE526585 T1 AT E526585T1
Authority
AT
Austria
Prior art keywords
rcc356
coupled receptor
natural ligand
protein
isovaleric acid
Prior art date
Application number
AT06707378T
Other languages
English (en)
Inventor
Frederic Sallman
Alex Veithen
Magali Philippeau
Original Assignee
Chemcom Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemcom Sa filed Critical Chemcom Sa
Application granted granted Critical
Publication of ATE526585T1 publication Critical patent/ATE526585T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06707378T 2005-03-03 2006-03-02 Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon ATE526585T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05447046 2005-03-03
PCT/EP2006/001904 WO2006094704A2 (en) 2005-03-03 2006-03-02 Natural ligand of g protein coupled receptor rcc356 and uses thereof

Publications (1)

Publication Number Publication Date
ATE526585T1 true ATE526585T1 (de) 2011-10-15

Family

ID=35344663

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06707378T ATE526585T1 (de) 2005-03-03 2006-03-02 Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon

Country Status (9)

Country Link
US (1) US8008023B2 (de)
EP (1) EP1864131B1 (de)
JP (1) JP5307404B2 (de)
AT (1) ATE526585T1 (de)
AU (1) AU2006222265B2 (de)
CA (1) CA2597255C (de)
DK (1) DK1864131T3 (de)
ES (1) ES2373913T3 (de)
WO (1) WO2006094704A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263417B2 (en) * 2006-01-04 2012-09-11 The Board Of Trustees Of The Leland Stanford Junior University Self-illuminating dot systems and methods of use thereof
JP4980418B2 (ja) * 2007-03-19 2012-07-18 株式会社リバース・プロテオミクス研究所 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法
GB201020133D0 (en) 2010-11-26 2011-01-12 Royal Holloway & Bedford New College Therapeutic use of compounds
US8637259B1 (en) * 2011-02-09 2014-01-28 Chemcom S.A. Methods of identifying modulators of olfactory receptors involved in the perception of sweat carboxylic acids
EP2753643A2 (de) * 2011-09-08 2014-07-16 Institut National De La Recherche Agronomique (INRA) Neuer pheromonrezeptor aus spodoptera littoralis (lepidoptera, noctuidae) und identifizierung eines natürlichen liganden des besagten rezeptors sowie seine verwendung
JP5948139B2 (ja) * 2012-05-11 2016-07-06 ヒノキ新薬株式会社 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤
WO2014191047A1 (en) 2013-05-31 2014-12-04 Chemcom S.A. Olfactory receptors involved in the perception of sweat carboxylic acids and the use thereof
WO2016123133A1 (en) * 2015-01-26 2016-08-04 The Johns Hopkins University Surface plasmon resonance approach to monitor protein-ligand interactions
JP6122181B2 (ja) 2015-06-17 2017-04-26 花王株式会社 スルフィド化合物の臭いの抑制剤の評価又は選択方法
JP6371336B2 (ja) 2015-06-17 2018-08-08 花王株式会社 ポリスルフィド化合物の臭いの抑制剤
KR20200037403A (ko) * 2017-08-17 2020-04-08 코미 핫코 코포레이션 냄새의 정량 방법, 그것에 이용되는 세포 및 그 세포의 제조방법
HUE061366T2 (hu) 2017-12-05 2023-06-28 Chemcom Sa A pézsmaillat érzékelésében résztvevõ szagreceptor és alkalmazása
CN112143547B (zh) * 2020-09-22 2022-07-15 上海桉欣新能源科技有限公司 一种制冷压缩机用润滑油及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361338B2 (en) * 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
IL147952A0 (en) * 1999-10-05 2002-08-14 Agensys Inc G protein-coupled receptor up-regulated in prostate cancer and uses thereof
CA2427858A1 (en) * 2000-11-03 2002-05-10 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20030096299A1 (en) * 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
JP4360915B2 (ja) * 2002-01-07 2009-11-11 ユーロスクリーン・ソシエテ・アノニム Ｇタンパク質共役受容体ｇｐｒ４３のリガンドおよびその使用

Also Published As

Publication number Publication date
DK1864131T3 (da) 2011-10-31
US8008023B2 (en) 2011-08-30
JP5307404B2 (ja) 2013-10-02
US20090264526A1 (en) 2009-10-22
WO2006094704A3 (en) 2006-11-09
ES2373913T3 (es) 2012-02-10
CA2597255C (en) 2014-05-27
JP2008538278A (ja) 2008-10-23
WO2006094704A2 (en) 2006-09-14
EP1864131B1 (de) 2011-09-28
AU2006222265A1 (en) 2006-09-14
AU2006222265B2 (en) 2012-07-05
EP1864131A2 (de) 2007-12-12
CA2597255A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
ATE526585T1 (de) Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
WO2011069156A3 (en) Compositions and methods for enhancing odorant receptor activity
MX2007008017A (es) Polipeptidos que se ligan a br3 y usos de los mismos.
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
ATE469895T1 (de) Cgrp-rezeptorantagonisten
CY1110579T1 (el) Η λειτουργια ενος υποδοχεα απτοσφαιρινης-αιμοσφαιρινης και οι χρησεις αυτου
WO2006002161A3 (en) Modulators of odorant receptors
NO20075580L (no) Silylert polymer avledet fra butadien og losningsmiddelresistent, trykksensitiv limsammensetning som inneholder denne
EA200702193A1 (ru) Гликозилирование белков
WO2007011907A3 (en) Alpha-synuclein antibodies and methods related thereto
EA200901646A1 (ru) Ингибиторы рецепторных тирозинкиназ и их применение
DK1778236T3 (da) Modificerede pyrimidin-glucocorticoid-receptor-modulatorer
DK2064348T3 (da) Profilering af receptorfamilie
NO20074002L (no) Androgen reseptor-modulatorforbindelser og fremgangsmater
MX2007015931A (es) Receptores de sabor dulce-umami y umami-dulce humanos quimericos.
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
ATE309543T1 (de) Natürlicher ligand von gpcr chemr23 und dessen verwendung
CY1115437T1 (el) Υδροξυμεθυλοκυκλοεξυλαμινες
ATE474834T1 (de) Als agonisten des gpr38-rezeptors geeignete biarylverbindungen
ATE556071T1 (de) Kappa-opioidrezeptor-liganden
NO20074277L (no) Kinnolinforbindelser og anvendelse derav som lever X reseptor modulatorer
ATE519498T1 (de) Kombination aus somatostatin-analoga unterschiedlicher selektivität für humane somatostatin-rezeptor-subtypen
NO20065806L (no) Peptid-baserte forbindelser
WO2006017748A3 (en) Materials and methods for identifying anti-schizophrenic agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1864131

Country of ref document: EP